Physiological Imaging Methods for Evaluating Response to Immunotherapies in Glioblastomas

Area of Science:

• Neuro-oncology
• Medical Imaging
• Immunotherapy

Background:

• Glioblastoma (GBM) is an aggressive brain tumor with poor outcomes.
• Immunotherapy offers a promising treatment for recurrent GBMs by leveraging the patient's immune system.
• Conventional MR imaging struggles to accurately assess immunotherapy response in GBM due to immune-related changes.

Purpose of the Study:

• To review current immunotherapeutic strategies for GBM.
• To highlight the limitations of standard imaging in evaluating immunotherapy response.
• To explore the potential of advanced neuroimaging techniques for accurate and early response assessment.

Main Methods:

• Review of existing literature on GBM immunotherapy.
• Discussion of conventional MR imaging limitations.
• Exploration of diffusion/perfusion MRI and amino acid-PET imaging for treatment response evaluation.

Main Results:

• Standard MR imaging is insufficient for assessing immunotherapy response in GBM.
• Physiologic imaging techniques like diffusion/perfusion MRI and PET show potential for early response assessment.
• These advanced methods aim to provide definitive metrics for treatment decisions.

Conclusions:

• There is a critical need for advanced neuroimaging in GBM immunotherapy.
• Diffusion/perfusion MRI and amino acid-PET are promising tools for monitoring treatment efficacy.
• Overcoming challenges in these imaging methods is crucial for optimizing patient care and therapeutic interventions.